The production of EudraCT Version 8.0 has been delayed. Consequently, Revision 4 dated November 2009 of the Clinical Trials Application Form will not apply yet and the current version of the Clinical Trial Application form Annex 1 (dated Oct 2005) will remain in force for the time being.

In addition, the new EU Clinical Trial Register, which is dependant upon EudraCT Version 8, is also delayed.

Further information on both deployments will be made available in the near future.

Source: https://eudract.ema.europa.eu/

Related GMP News
08/02/2012	New Questions and Answers about the Centralised Procedure - EMA publishes an Updated Q&A Document
01/02/2012	FDA: QbD becomes mandatory for Generics
09/11/2011	New QP Declaration for managing Expiry Dates of IMPs
09/11/2011	MHRA announces Good Clinical Practice (GCP) Discussion Forum
26/10/2011	CHMP adopts Guideline on Quality Aspects on the Isolation of Candidate Influenza Vaccine Viruses